Truist Securities Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $117
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter maintains a Hold rating on Zimmer Biomet Holdings (NYSE:ZBH) and lowers the price target from $130 to $117.
July 16, 2024 | 2:07 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Truist Securities analyst Richard Newitter maintains a Hold rating on Zimmer Biomet Holdings and lowers the price target from $130 to $117.
The lowered price target from $130 to $117 by Truist Securities suggests a less optimistic outlook for Zimmer Biomet Holdings. This could lead to a short-term negative impact on the stock price as investors may adjust their expectations accordingly.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100